...
首页> 外文期刊>Indian journal of pharmaceutical sciences. >Formulation and optimization of sustained release tablets of venlafaxine resinates using response surface methodology
【24h】

Formulation and optimization of sustained release tablets of venlafaxine resinates using response surface methodology

机译:响应面法研究文拉法辛树脂酸酯缓释片的配方和优化

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of the current study was to design sustained release matrix tablets of venlafaxine hydrochloride using ion exchange resin with the incorporation of hydrophilic and hydrophobic polymer combinations. Venlafaxine HCl was loaded onto Indion 244 by batch method and then resinate were wet granulated with ethyl cellulose and blended with hydroxypropylmethylcellulose and compressed. A central composite design for 2 factors at 3 levels each was employed to systematically optimize drug release profile at 2 h and at 18 h. Hydroxypropylmethylcellulose and ethylcellulose were taken as the independent variables. Response surface plots and contour plots were drawn, and optimum formulations were selected by feasibility and grid searches. Resinate shows inadequate sustained release profile. Compressed matrices exhibited the anomalous release mechanism, as the value of release rate exponent (n) varied between 08109 and 08719, resulting in regulated and complete release until 20 h. Validation of optimization study, performed using five confirmatory runs, indicated very high degree of prognostic ability of response surface methodology, with mean percentage error as 1.1521.88%. Regulated drug release study indicates that the hydrophilic and hydrophobic matrix tablets of venlafaxine resinate prepared using hydroxypropylmethylcellulose and ethylcellulose, can successfully be employed as a once-a-day oral controlled release drug delivery system.
机译:本研究的目的是使用离子交换树脂结合亲水性和疏水性聚合物的组合设计盐酸文拉法辛的缓释基质片剂。盐酸文拉法辛通过分批法装载到Indion 244上,然后将树脂酸盐用乙基纤维素湿法制粒,并与羟丙基甲基纤维素混合并压缩。采用中央复合设计,分别针对3个水平的2个因子,以系统优化2 h和18 h的药物释放曲线。羟丙基甲基纤维素和乙基纤维素作为自变量。绘制了响应面图和轮廓图,并通过可行性和网格搜索选择了最佳配方。树脂显示持续释放特性不足。压缩基质表现出异常的释放机理,因为释放速率指数(n)的值在08109和08719之间变化,导致调节释放和完全释放直至20 h。使用五次验证性运行进行的优化研究的验证表明,响应面方法的预后能力非常高,平均百分比误差为1.1521.88%。调节药物释放研究表明,使用羟丙基甲基纤维素和乙基纤维素制备的文拉法辛树脂酸酯的亲水性和疏水性基质片剂可以成功地用作每日一次的口服控释药物递送系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号